Our focus is expanding affordable access to NARCAN® (naloxone HCl) Nasal Spray - the leading
community use naloxone - and progressing our pipeline of opioid overdose and addiction treatments.

MENU

Latest News

Adapting
for the patient

Emergent BioSolutions Completes Acquisition of Adapt Pharma and Flagship Product Narcan® (naloxone HCI) Nasal Spray

Learn More

Our Focus

Our focus is expanding affordable access to NARCAN® Nasal Spray – the leading community use naloxone – and progressing our pipeline of opioid overdose and addiction treatments.

About Emergent BioSolutions in the US Specialty Pharma Industry

Emergent BioSolutions Inc. is a global life sciences company seeking to protect and enhance life by focusing on providing specialty products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. Through our work, we envision protecting and enhancing 50 million lives with our products by 2025.

Learn More